Aspirin soon after certain bleeding stroke, after clot-busting therapy
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial studies whether starting aspirin early is safe and helpful for people who, after clot-busting treatment for an ischemic stroke, develop a specific type of small brain bleeding called hemorrhagic infarction. You might benefit if your scan later shows this pattern of bleeding and you are not able to take blood-thinners or aspirin is safe for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an ischemic stroke treated with IV clot-busting medicine within 24 hours of symptom start
- Your follow-up CT scan at 24 to 36 hours after the IV treatment shows hemorrhagic infarction (a specific type of bleeding)
- You (or your legal representative) agree to join the study by signing consent
- You have NOT taken anticoagulant (blood-thinning) medicine within 1 week after the IV treatment
- You did NOT receive certain additional procedures/medicines after treatment, like tirofiban after endovascular therapy or a stent placed during surgery
- A doctor says aspirin is safe for you (no aspirin allergy or other reason you can’t take aspirin)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a clot-busting medication given through a vein (intravenous thrombolysis) can safely treat acute ischemic stroke within 24 hours in people who have taken a newer oral blood thinner (NOAC) within the last 4 to 48 hours.
This trial is testing the best time to start blood thinners (anticoagulation) after emergency stroke treatment in people who have atrial fibrillation. It is for patients who had a certain type of bleeding in the brain after the procedure.
This study tests whether taking aspirin early (within 24 hours) after receiving clot-busting medication for a stroke helps prevent another stroke. You'll receive the standard clot-busting treatment, then take low-dose aspirin to see if it improves recovery.
This trial tests whether giving an antiplatelet medicine (like aspirin) early—within 3 hours of a clot-busting drug—can help prevent another stroke without causing bleeding. It is for people who still have moderate to severe stroke symptoms after the clot-buster and do not have a large artery blockage.
This trial tests whether a common antiplatelet medicine can reduce the risk of future heart attacks, strokes, or blood clots in people who have had a brain bleed. It's for adults who had their first brain bleed and can start treatment within 3 months of the stroke.
This trial tests whether a combination of a clot-preventing drug (tirofiban) followed by two antiplatelet drugs (aspirin and clopidogrel) can improve recovery in people who have had a mild stroke. It aims to find a better way to prevent further strokes or worsening symptoms.
Hear when a new Antiplatelet Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.